Development
Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 527.69% | 1,112.10% | 517.95% | -25.37% | -78.41% |
| Total Receivables | -52.08% | 4.28% | -37.45% | -25.64% | -55.56% |
| Inventory | -36.97% | -47.91% | -47.10% | -47.19% | -34.26% |
| Prepaid Expenses | 9.17% | -73.72% | -39.87% | -38.10% | -8.76% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -6.90% | -- |
| Total Current Assets | -3.75% | -7.44% | -38.44% | -36.29% | -43.57% |
|
|
|||||
| Total Current Assets | -3.75% | -7.44% | -38.44% | -36.29% | -43.57% |
| Net Property, Plant & Equipment | -34.35% | -33.12% | -33.04% | -30.68% | -27.80% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -27.32% | -27.80% | -34.14% | -31.81% | -55.53% |
|
|
|||||
| Total Accounts Payable | 65.69% | 70.55% | 64.17% | 90.30% | 105.95% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -39.09% | -23.18% | 29.93% | 92.89% | 114.13% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -43.45% | -9.75% | -16.49% | 0.86% | 2.41% |
| Total Finance Division Other Current Liabilities | -- | -- | 2,150.00% | -46.74% | -- |
| Total Other Current Liabilities | -- | -- | 2,150.00% | -46.74% | -- |
| Total Current Liabilities | 17.58% | 30.75% | 60.10% | 78.51% | 93.41% |
|
|
|||||
| Total Current Liabilities | 17.58% | 30.75% | 60.10% | 78.51% | 93.41% |
| Long-Term Debt | 908.39% | 559.34% | -- | -- | -- |
| Short-term Debt | -39.09% | -23.18% | 29.93% | 92.89% | 114.13% |
| Capital Leases | -- | -- | -- | -92.55% | -75.40% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 56.44% | 51.30% | 51.75% | 62.57% | 69.20% |
|
|
|||||
| Common Stock & APIC | 0.66% | -2.59% | -13.46% | -4.21% | 20.98% |
| Retained Earnings | -10.26% | -5.90% | -2.92% | -4.52% | -30.71% |
| Treasury Stock & Other | 6.92% | -0.08% | 96.04% | -4.64% | -50.54% |
| Total Common Equity | -217.04% | -276.76% | -822.30% | -1,088.66% | -138.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -217.04% | -276.76% | -822.30% | -1,088.66% | -138.64% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -217.04% | -276.76% | -822.30% | -1,088.66% | -138.64% |
|
|
|||||